Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Dabur India Limited (DABUR.NS)
Ghaziabad, IN
Dabur India Limited functions as a leading global fast-moving consumer goods (FMCG) enterprise, conducting its operations through distinct Consumer Care Business, Foods Business, Retail Business, and Other segments. Its comprehensive product portfolio encompasses a diverse array of health supplements, such as Dabur Chyawanprash, Dabur Vita, Dabur Honey, Dabur Immunity Kit, Dabur Vedic Suraksha Tea, and Dabur Glucose. The company also offers digestive aids including Dabur Hajmola, Pudin Hara, Hingoli, Dabur Nature Care, and Sat Isabgol. In the realm of personal care, Dabur provides shampoos like Dabur Almond and Vatika, alongside hair oils marketed under the Dabur Amla, Vatika, Dabur Almond, and Anmol brands. Its skincare collection features Dabur Gulabari, Oxylife, and Dabur Fem, while its oral hygiene solutions include Dabur Red Paste, Dabur Meswak, Dabur Babool, Dabur Lal Dant Manjan, Dabur Red Pulling Oil, and Dabur Dant Rakshak Ayurvedic Paste. The company’s food and beverage division supplies fruit juices (Real, Real Activ), cooking pastes (Hommade), and milk-based beverages (Real Milk Power). Furthermore, Dabur's health and wellness offerings extend to energizers and rejuvenators such as Shilajit, Shilajit Gold, Shilajit Double Gold, and Dabur Musli Gold. It addresses cough and cold symptoms with Dabur Honitus and Dabur Tulsi Drops, produces various health juices, and offers women's health products like Dabur Dashmularishta and Dabur Ashokarishta. An Ayurvedic baby massage oil, Dabur Lal Tail, and other ethical Ayurvedic products are also part of its range. Beyond health and personal care, Dabur provides household essentials, including Odomos mosquito repellent, Odonil air freshener, Sanifresh Shine toilet cleaner, Odopic dish wash, and DABISCO natural gum products. Additionally, Dabur operates specialized beauty retail stores under the NewU brand, which feature a curated selection of cosmetics, fragrances, skincare, personal care items, and fashion accessories. Dabur India Limited was established in 1884 and maintains its headquarters in Ghaziabad, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.27% | +1.11% | +8.92% | -8.66% | -9.14% | -5.77% | -0.11% | -8.45% | -10.33% | +62.85% | +6,347.69% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 7 | 0 |
| Buy | 10 | 0 |
| Hold | 16 | 0 |
| Sell | 3 | -1 |
| Strong Sell | 3 | +1 |
-
Revenue growth Household & Personal Products: +3.3%+5.0% ★ Q1'26: +7.3% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+7.1% Q1'26: +15.0% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+12.6% Q1'26: +19.4% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+15.0% ★ Q1'26: +11.2% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+19.3% ★ Q1'26: +13.1% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.53× ★ Q1'26: 0.70× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 36 Rev. Ana. 30 EPS Ana. |
Mar 2027 36 Rev. Ana. 30 EPS Ana. |
Mar 2028 37 Rev. Ana. 29 EPS Ana. |
Mar 2029 17 Rev. Ana. 13 EPS Ana. |
Mar 2030 8 Rev. Ana. 11 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
40.37B
est: 41.08B (-1.7%)
|
52.84B
est: 53.00B (-0.3%)
|
61.56B
est: 63.01B (-2.3%)
|
78.11B
est: 71.97B (+8.5%)
|
78.11B
est: 79.37B (-1.6%)
|
77.80B
est: 84.13B (-7.5%)
|
76.14B
est: 81.90B (-7.0%)
|
77.22B
est: 79.75B (-3.2%)
|
85.15B
est: 86.85B (-2.0%)
|
86.85B
est: 90.84B (-4.4%)
|
95.62B
est: 96.43B (-0.8%)
|
108.89B
est: 109.16B (-0.3%)
|
115.30B
est: 116.21B (-0.8%)
|
124.04B
est: 126.23B (-1.7%)
|
125.63B
est: 126.64B (-0.8%)
|
131.98B
130.14B – 141.49B
+4.2% YoY
|
143.73B
141.09B – 146.28B
+8.9% YoY
|
156.18B
151.44B – 162.56B
+8.7% YoY
|
168.85B
168.32B – 169.38B
+8.1% YoY
|
189.20B
184.54B – 194.83B
+12.1% YoY
|
| EBITDA |
7.75B
est: 7.75B (-0.1%)
|
9.19B
est: 9.54B (-3.7%)
|
10.08B
est: 10.27B (-1.8%)
|
13.39B
est: 12.18B (+10.0%)
|
13.39B
est: 14.48B (-7.5%)
|
15.31B
est: 16.32B (-6.2%)
|
15.12B
est: 18.05B (-16.2%)
|
16.28B
est: 19.96B (-18.4%)
|
17.46B
est: 22.73B (-23.2%)
|
17.58B
est: 22.04B (-20.2%)
|
19.78B
est: 21.50B (-8.0%)
|
22.25B
est: 23.93B (-7.0%)
|
21.47B
est: 26.52B (-19.1%)
|
23.83B
est: 23.99B (-0.7%)
|
22.86B
est: 24.31B (-6.0%)
|
25.09B
24.74B – 26.89B
+3.2% YoY
|
27.32B
26.82B – 27.81B
+8.9% YoY
|
29.69B
28.79B – 30.90B
+8.7% YoY
|
32.10B
31.99B – 32.20B
+8.1% YoY
|
35.96B
35.08B – 37.04B
+12.1% YoY
|
| EBIT |
7.33B
est: 6.83B (+7.3%)
|
8.21B
est: 8.70B (-5.6%)
|
9.24B
est: 9.38B (-1.5%)
|
12.24B
est: 10.58B (+15.7%)
|
12.24B
est: 11.88B (+3.0%)
|
14.03B
est: 12.93B (+8.5%)
|
13.75B
est: 13.64B (+0.8%)
|
14.71B
est: 13.80B (+6.6%)
|
15.74B
est: 15.94B (-1.2%)
|
15.80B
est: 15.71B (+0.6%)
|
17.78B
est: 14.68B (+21.1%)
|
20.15B
est: 16.34B (+23.3%)
|
18.79B
est: 18.11B (+3.8%)
|
20.31B
est: 20.52B (-1.0%)
|
18.94B
est: 20.79B (-8.9%)
|
21.45B
21.16B – 23.00B
+3.2% YoY
|
23.36B
22.93B – 23.78B
+8.9% YoY
|
25.39B
24.62B – 26.42B
+8.7% YoY
|
27.45B
27.36B – 27.53B
+8.1% YoY
|
30.76B
30.00B – 31.67B
+12.1% YoY
|
| Net Income |
5.61B
est: 5.96B (-5.9%)
|
6.45B
est: 7.23B (-10.8%)
|
7.63B
est: 7.66B (-0.3%)
|
10.66B
est: 8.80B (+21.1%)
|
10.66B
est: 10.25B (+4.0%)
|
12.51B
est: 11.34B (+10.3%)
|
12.77B
est: 12.21B (+4.5%)
|
13.54B
est: 12.78B (+6.0%)
|
14.42B
est: 14.75B (-2.2%)
|
14.45B
est: 15.08B (-4.2%)
|
16.93B
est: 14.27B (+18.6%)
|
17.39B
est: 15.88B (+9.5%)
|
17.07B
est: 17.61B (-3.1%)
|
18.43B
est: 18.79B (-1.9%)
|
17.68B
est: 17.81B (-0.8%)
|
18.95B
18.62B – 20.60B
+6.4% YoY
|
20.84B
19.81B – 22.22B
+10.0% YoY
|
23.30B
22.15B – 25.17B
+11.8% YoY
|
26.11B
25.05B – 28.52B
+12.0% YoY
|
30.22B
29.25B – 31.39B
+15.7% YoY
|
| SGA |
8.52B
est: 13.14B (-35.2%)
|
9.81B
est: 14.09B (-30.4%)
|
19.47B
est: 19.45B (+0.1%)
|
18.91B
est: 23.31B (-18.9%)
|
18.91B
est: 19.09B (-0.9%)
|
16.46B
est: 29.36B (-43.9%)
|
15.17B
est: 25.23B (-39.8%)
|
14.78B
est: 24.34B (-39.2%)
|
16.32B
est: 22.61B (-27.8%)
|
16.45B
est: 24.26B (-32.2%)
|
18.61B
est: 23.57B (-21.1%)
|
19.10B
est: 26.23B (-27.2%)
|
18.38B
est: 29.08B (-36.8%)
|
21.47B
est: 22.14B (-3.0%)
|
22.18B
est: 36.67B (-39.5%)
|
23.15B
22.83B – 24.82B
-36.9% YoY
|
25.21B
24.75B – 25.66B
+8.9% YoY
|
27.40B
26.56B – 28.51B
+8.7% YoY
|
29.62B
29.52B – 29.71B
+8.1% YoY
|
33.19B
32.37B – 34.18B
+12.1% YoY
|
| EPS |
3.27
est: 3.40 (-3.9%)
|
3.70
est: 3.81 (-2.8%)
|
4.38
est: 4.52 (-3.2%)
|
6.08
est: 5.38 (+13.0%)
|
6.08
est: 6.10 (-0.4%)
|
7.12
est: 7.08 (+0.6%)
|
7.25
est: 7.34 (-1.2%)
|
7.69
est: 7.76 (-0.9%)
|
8.17
est: 8.65 (-5.5%)
|
8.18
est: 9.20 (-11.1%)
|
9.58
est: 10.01 (-4.3%)
|
9.84
est: 10.57 (-6.9%)
|
9.64
est: 10.38 (-7.2%)
|
10.40
est: 10.60 (-1.9%)
|
9.97
est: 10.28 (-3.0%)
|
10.76
10.47 – 11.59
+4.7% YoY
|
11.80
11.14 – 12.50
+9.6% YoY
|
13.16
12.46 – 14.16
+11.6% YoY
|
15.02
14.09 – 16.04
+14.1% YoY
|
17.00
16.46 – 17.66
+13.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR MSCI Emerging Markets StrategicFactors ETF QEMM | 0.04% | 22.6K | 0.30% |
| 2 | Schwab Emerging Markets Equity ETF SCHE | 0.03% | 3.41M | 0.06% |
| 3 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.03% | 4.57M | 0.07% |
| 4 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.03% | 113.2K | 0.49% |
| 5 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.02% | 141.5K | 0.44% |
| 6 | State Street SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF EEMX | 0.02% | 38.6K | 0.30% |
| 7 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.02% | 1.57M | 0.29% |
| 8 | State Street SPDR MSCI ACWI ex-US ETF CWI | 0.01% | 395.0K | 0.30% |
| 9 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 42.8K | 0.56% |
| 10 | State Street SPDR MSCI ACWI Climate Paris Aligned ETF NZAC | 0.01% | 23.4K | 0.12% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Pritam Das Narang AICWA MIIA | Group Director of Corporation Affairs & Whole Time Director | 175M | male |
| Mohit Malhotra | Global CEO & Whole Time Director | 158M | male |
| Ashok Kumar Jain | EVP of Finance, Joint Chief Risk Officer & Chief Compliance Officer | — | male |
| Biplab Baksi | Chief Human Resource Officer | — | male |
| Byas Anand | Head of Corporate Communications and CSR | — | male |
| Isha Lamba | Head of Investor Relations and M&A | — | female |
| Rehan Hasan | Head of Sales | — | male |
| A. Sudhakar | Head of Corporate Social Responsibility | — | male |
| Saurabhkumar Narendra Lal | Executive Director of Operations | — | male |
| Ankush Jain | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DABUR.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
